Danaher Corporation (DHR)

USD 228.3

(-2.24%)

EBITDA Summary of Danaher Corporation

  • Danaher Corporation's latest annual EBITDA in 2023 was 7.54 Billion USD , down -27.69% from previous year.
  • Danaher Corporation's latest quarterly EBITDA in 2024 Q1 was 1.89 Billion USD , up 5.14% from previous quarter.
  • Danaher Corporation reported an annual EBITDA of 9.71 Billion USD in 2022, up 6.19% from previous year.
  • Danaher Corporation reported an annual EBITDA of 10 Billion USD in 2021, up 65.14% from previous year.
  • Danaher Corporation reported a quarterly EBITDA of 1.65 Billion USD for 2024 Q3, down -5.32% from previous quarter.
  • Danaher Corporation reported a quarterly EBITDA of 1.74 Billion USD for 2024 Q2, down -9.15% from previous quarter.

Annual EBITDA Chart of Danaher Corporation (2023 - 1989)

Historical Annual EBITDA of Danaher Corporation (2023 - 1989)

Year EBITDA EBITDA Growth
2023 7.54 Billion USD -27.69%
2022 9.71 Billion USD 6.19%
2021 10 Billion USD 65.14%
2020 6.59 Billion USD 32.67%
2019 4.6 Billion USD -3.11%
2018 4.27 Billion USD 9.63%
2017 4.33 Billion USD 5.78%
2016 4.03 Billion USD -9.6%
2015 3.2 Billion USD -0.11%
2014 4.54 Billion USD 8.8%
2013 4.6 Billion USD 4.18%
2012 4 Billion USD 23.05%
2011 3.22 Billion USD 13.87%
2010 2.86 Billion USD 51.42%
2009 1.88 Billion USD -14.86%
2008 2.21 Billion USD 11.22%
2007 2.01 Billion USD 16.06%
2006 1.74 Billion USD 18.85%
2005 1.45 Billion USD 15.41%
2004 1.26 Billion USD 30.95%
2003 979.43 Million USD 16.96%
2002 824.41 Million USD -0.21%
2001 750.12 Million USD 16.81%
2000 701.87 Million USD 17.72%
1999 584.4 Million USD 15.48%
1998 498.7 Million USD 50.52%
1997 343 Million USD 16.35%
1996 294.8 Million USD 23.45%
1995 238.8 Million USD 25.35%
1994 190.5 Million USD 51.79%
1993 133.9 Million USD 37.01%
1992 98.1 Million USD 47.03%
1991 68.1 Million USD -32.71%
1990 101.2 Million USD -10.52%
1989 113.1 Million USD -7.45%

Peer EBITDA Comparison of Danaher Corporation

Name EBITDA EBITDA Difference
Agilent Technologies, Inc. 1.67 Billion USD -350.03%
Charles River Laboratories International, Inc. 1.03 Billion USD -631.215%
Quest Diagnostics Incorporated 1.73 Billion USD -335.739%
Enzo Biochem, Inc. -8.34 Million USD 90504.887%
IQVIA Holdings Inc. 3.25 Billion USD -131.787%
Laboratory Corporation of America Holdings 1.34 Billion USD -459.286%
Mettler-Toledo International Inc. 1.18 Billion USD -537.869%
Qiagen N.V. 650.58 Million USD -1060.036%
Revvity, Inc. 813.25 Million USD -828.001%
Thermo Fisher Scientific Inc. 10.8 Billion USD 30.12%
Waters Corporation 1.02 Billion USD -638.273%